• ‘This looks like the real deal': are we inching closer to a treatment for Alzheimer's?

    8 days ago - By The Guardian

    After years of setbacks, dementia researchers are getting excited about a new antibody drug called lecanemab. No one expects it to stop cognitive decline, but even slowing it would be a breakthrough At the end of November, thousands of researchers from around the world will descend on San Francisco for the annual Clinical Trials on Alzheimer's Disease meeting. The conference is a mainstay of the dementia research calendar, the place where the latest progress - and all too often, setbacks - in the quest for Alzheimer's treatments are made public for the first time. This year's meeting is...
    Read more ...